Patent · US Active

Macrocyclic inhibitors of hepatitis C virus

US8153800B2 · kind B2 · utility

7Cited by

9References

7Claims

0Family size

Assignees

Tibotec Pharmaceuticals Ltd. · IE
Medivar AB · SE

Inventors

Kenneth Alan Simmen · Tervuren, BE
Herman Augustinus De Kock · Arendonk, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Karl Magnus Nilsson · Vimmerby, SE
Bengt Bertril Samuelsson · Huddinge, SE
Asa Annica Kristina Rosenquist · Huddinge, SE

Key dates

Filing date	Aug 3, 2011
Grant date	Apr 10, 2012
Priority date	—
Expiry date	Aug 3, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.